These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 11140685)

  • 41. [Immunization witha synthetic fragment 155-164 of neurotrophin receptor p75 prevents memory loss and decreases beta-amyloid level in mice with experimentally induced Alzheimer's disease].
    Vol'pina OM; Medvinskaia NI; Kamynina AV; Zaporozhskaia IaV; Aleksandrova IIu; Koroev DO; Samokhin AN; Volkova TD; Arsen'ev AS; Bobkova NV
    Bioorg Khim; 2014; 40(4):451-7. PubMed ID: 25898755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease.
    Dorr A; Sahota B; Chinta LV; Brown ME; Lai AY; Ma K; Hawkes CA; McLaurin J; Stefanovic B
    Brain; 2012 Oct; 135(Pt 10):3039-50. PubMed ID: 23065792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A promising rat model of Alzheimer's disease-like neuropathology.
    Pluta R; Misicka A; Barcikowska M; Januszewski S; Lipkowski AW
    Folia Morphol (Warsz); 1996; 55(4):417-9. PubMed ID: 9243932
    [No Abstract]   [Full Text] [Related]  

  • 45. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.
    Lai AY; Dorr A; Thomason LA; Koletar MM; Sled JG; Stefanovic B; McLaurin J
    Brain; 2015 Apr; 138(Pt 4):1046-58. PubMed ID: 25688079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alzheimer's disease. In the beginning..
    Selkoe DJ
    Nature; 1991 Dec; 354(6353):432-3. PubMed ID: 1684220
    [No Abstract]   [Full Text] [Related]  

  • 47. Alzheimer's disease: model behaviour.
    Chapman PF
    Nature; 2000 Dec 21-28; 408(6815):915-6. PubMed ID: 11140660
    [No Abstract]   [Full Text] [Related]  

  • 48. Transgenic mouse and chemical lesion approaches to the study of Alzheimer's disease.
    Tang F; Li H; Nag S; Xu G; Chan T
    Chin Med J (Engl); 1997 Aug; 110(8):642-7. PubMed ID: 9594272
    [No Abstract]   [Full Text] [Related]  

  • 49. Gel electrophoretic distinction between toxic and nontoxic forms of beta-amyloid (1-40).
    Brining SK; Chen N; Yi D; Chrambach A
    Electrophoresis; 1999 Jun; 20(7):1398-402. PubMed ID: 10424461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination as a therapeutic approach to Alzheimer's disease.
    Wisniewski T; Boutajangout A
    Mt Sinai J Med; 2010; 77(1):17-31. PubMed ID: 20101719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An Alzheimer's advance.
    Cowley G
    Newsweek; 1999 Nov; 134(18):76. PubMed ID: 10662107
    [No Abstract]   [Full Text] [Related]  

  • 52. Whole-food diet worsened cognitive dysfunction in an Alzheimer's disease mouse model.
    Parrott MD; Winocur G; Bazinet RP; Ma DW; Greenwood CE
    Neurobiol Aging; 2015 Jan; 36(1):90-9. PubMed ID: 25212462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid drug screening for Alzheimer's.
    Döbeli H
    Nat Biotechnol; 1997 Mar; 15(3):223-4. PubMed ID: 9062918
    [No Abstract]   [Full Text] [Related]  

  • 54. Amyloid, aluminum and the aetiology of Alzheimer's disease.
    Exley C
    Med J Aust; 1996 Feb; 164(4):252-3. PubMed ID: 8604204
    [No Abstract]   [Full Text] [Related]  

  • 55. Towards Alzheimer's disease vaccination.
    Solomon B
    Mini Rev Med Chem; 2002 Feb; 2(1):85-92. PubMed ID: 12369959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer's Disease.
    Cao C; Hasegawa Y; Hayashi K; Takemoto Y; Kim-Mitsuyama S
    J Alzheimers Dis; 2019; 69(1):297-309. PubMed ID: 30958350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloid-beta immunization in Alzheimer's disease transgenic mouse models and wildtype mice.
    Lemere CA; Spooner ET; Leverone JF; Mori C; Iglesias M; Bloom JK; Seabrook TJ
    Neurochem Res; 2003 Jul; 28(7):1017-27. PubMed ID: 12737526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Battling Alzheimer's disease, step by small step. Transforming growth factor (tgf-beta) and low brain oxygen levels provide more clues to AD.
    Duke Med Health News; 2007 Feb; 13(2):7. PubMed ID: 17328129
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro screening on β-amyloid peptide production of plants used in traditional medicine for cognitive disorders.
    Hage S; Kienlen-Campard P; Octave JN; Quetin-Leclercq J
    J Ethnopharmacol; 2010 Oct; 131(3):585-91. PubMed ID: 20673795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Model mice. Transgenic animals and Alzheimer's research.
    Erickson D
    Sci Am; 1991 Sep; 265(3):34. PubMed ID: 1925493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.